Schedule 13G ownership disclosure
REATA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75615P103
Event date: 2022-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 372,165
- Percent of class
- 1.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-22-000324
- Form type
- SC 13G
- Filer
- Invesco Ltd.
- CIK
- CIK 914208
- Filed
- Mar 10, 2022
- Reporting period
- Feb 28, 2022
- Description
- Schedule 13G beneficial ownership